Sara Demy

@demy_sara

A biotech enthusiast, who gets a kick out of spending time with super smart people looking to do good; an unashamed dog lover; and a fine kitchen chemist.

New York
Vrijeme pridruživanja: travanj 2017.

Tweetovi

Blokirali ste korisnika/cu @demy_sara

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @demy_sara

  1. Prikvačeni tweet
    19. ruj 2019.

    I am more than excited to announce the launch of a brand new conference in the lineup! will discuss the most controversial and important topics in and .

    Poništi
  2. proslijedio/la je Tweet
    21. lis 2019.

    "Sara Demy the founder of , half jokingly calls it H&Q 2.0." Check out this article by on his thoughts from last year's JPM Healthcare Conference, as January is around the corner!

    Poništi
  3. 10. lis 2019.

    ICYMI - On the Importance of Invite Only, Off Record CEO Summits.

    Poništi
  4. proslijedio/la je Tweet
    30. ruj 2019.

    is about working with , tech, service providers, patients and the financial community, to foster cross-collaboration and investment to develop innovative new treatments faster, and ultimately improve healthcare outcomes.

    Poništi
  5. proslijedio/la je Tweet
    27. ruj 2019.

    Happy Friday! Throwing back some photos from our in . Fireside chats, case studies and group discussions address a range of global issues key to CEOs and their teams. Join us next year!

    Poništi
  6. proslijedio/la je Tweet
    25. ruj 2019.

    Locus co-founders find that a different type of system works in human cells, opening door to new therapeutic opportunities

    Poništi
  7. proslijedio/la je Tweet
    23. ruj 2019.

    How Flagship's latest white space company plans to target chromatin structures

    Poništi
  8. proslijedio/la je Tweet
    24. ruj 2019.

    Biotech CEO Summits provide relationship-building opportunities through informal discussions where personal knowledge, insights, and ideas are exchanged with peers. Learn more about our summits in Napa Valley and Europe here:

    Poništi
  9. proslijedio/la je Tweet
    23. ruj 2019.

    BioFuture will feature today’s leading companies, investors, and innovators in and , who will share their vision about how this sector will change while delivering unprecedented advances in . Find out more here:

    Poništi
  10. proslijedio/la je Tweet
    19. ruj 2019.

    Demy-Colton Launches BioFuture in New York Spotlighting Disruptive Forces and Investment Opportunities in Healthcare and Digital Health

    Poništi
  11. proslijedio/la je Tweet
    19. ruj 2019.

    Excited to announce , a new conference we're launching, which will feature the most disruptive companies and speakers in the healthcare & tech industry! More info here:

    Poništi
  12. 13. kol 2019.

    Protagonist Therapeutics Reports Second Quarter 2019 Financial Results

    Poništi
  13. 13. kol 2019.

    Lexicon Posts Positive 52-Week Pooled Zynquista Data in Type 1 Diabetes

    Poništi
  14. 13. kol 2019.

    Research Roundup: Possible Melanoma Vaccine and More

    Poništi
  15. 12. kol 2019.

    Assembly Biosciences Announces Appointment of John McHutchison, AO, MD, as President and Chief Executive Officer

    Poništi
  16. 12. kol 2019.

    AstraZeneca's Tagrisso Improved Progression-Free Survival in Lung Cancer Trial

    Poništi
  17. 12. kol 2019.

    Sonnet bags ex-Serono neuropathy drug via Relief Therapeutics deal

    Poništi
  18. 12. kol 2019.

    Analysts track doubling in number of private biotech rounds

    Poništi
  19. 11. kol 2019.
    Poništi
  20. 11. kol 2019.

    Medicare boosts CAR-T cancer therapies with expanded coverage

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·